Vivos Therapeutics, Inc. (VVOS)
NASDAQ: VVOS · Real-Time Price · USD
0.3053
+0.0193 (6.75%)
At close: Aug 13, 2026, 4:00 PM EDT
0.3054
+0.0001 (0.03%)
After-hours: Aug 13, 2026, 7:59 PM EDT
Vivos Therapeutics Revenue
Vivos Therapeutics had revenue of $5.14M in the quarter ending March 31, 2026, with 70.46% growth. This brings the company's revenue in the last twelve months to $19.57M, up 33.77% year-over-year. In the year 2025, Vivos Therapeutics had annual revenue of $17.44M with 16.05% growth.
Revenue (ttm)
$19.57M
Revenue Growth
+33.77%
P/S Ratio
0.22
Revenue / Employee
$72,474
Employees
270
Market Cap
4.24M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 17.44M | 2.41M | 16.05% |
| Dec 31, 2024 | 15.03M | 1.23M | 8.91% |
| Dec 31, 2023 | 13.80M | -2.22M | -13.87% |
| Dec 31, 2022 | 16.02M | -861.00K | -5.10% |
| Dec 31, 2021 | 16.89M | 3.82M | 29.23% |
| Dec 31, 2020 | 13.07M | 1.67M | 14.68% |
| Dec 31, 2019 | 11.39M | 7.60M | 200.43% |
| Dec 31, 2018 | 3.79M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| WORK Medical Technology Group LTD | 9.85M |
| Beyond Air | 7.68M |
| Picard Medical | 5.47M |
| Tenon Medical | 4.60M |
| Biomerica | 4.33M |
| Intelligent Bio Solutions | 3.91M |
| VolitionRx | 2.47M |
| ENvue Medical | 2.18M |
VVOS News
- 2 days ago - Vivos Therapeutics expands strategic engagement with Greenway Health - TheFly
- 2 days ago - Vivos Therapeutics Expands Greenway Health Partnership to Deploy AI-Enabled Platform Across All Clinical and Revenue Operations - GlobeNewsWire
- 8 days ago - Vivos Therapeutics issued new U.S. patent for Vivos CARE devices - TheFly
- 8 days ago - Vivos Therapeutics Announces Issuance of New US Patent Broadening Protection for Its Vivos CARE Oral Medical Device Technology - GlobeNewsWire
- 5 weeks ago - Vivos Therapeutics price target lowered to 75c from $1.75 at Alliance Global - TheFly
- 6 weeks ago - Vivos Therapeutics says Vida oral appliance improves insomnia in study - TheFly
- 6 weeks ago - Vivos' Vida® Appliance Shows Statistically Significant Improvement in Insomnia Severity in 100% of Study Participants - GlobeNewsWire
- 7 weeks ago - Vivos Therapeutics and Streeterville Extend Timeframe of Strategic Financing Agreement and Reaffirm Commitment to Convert Debt Into Common Stock and Perpetual Preferred Equity - GlobeNewsWire